{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:17:40Z","timestamp":1787505460868,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070403"],"award-info":[{"award-number":["82070403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270374"],"award-info":[{"award-number":["82270374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Program of Guangdong Province","award":["2021A0505030031"],"award-info":[{"award-number":["2021A0505030031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Calcific aortic valve disease (CAVD) is the most prevalent valvular disease and has high morbidity and mortality. CAVD is characterized by complex pathophysiological processes, including inflammation-induced osteoblastic differentiation in aortic valve interstitial cells (AVICs). Novel anti-CAVD agents are urgently needed. Protein tyrosine phosphatase nonreceptor type 22 (PTPN22), an intracellular nonreceptor-like protein tyrosine phosphatase, is involved in several chronic inflammatory diseases, including rheumatoid arthritis and diabetes. However, it is unclear whether PTPN22 is involved in the pathogenesis of CAVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We obtained the aortic valve tissue from human and cultured AVICs from aortic valve. We established CAVD mice model by wire injury. Transcriptome sequencing, western bolt, qPCR, and immunofluorescence were performed to elucidate the molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we determined that PTPN22 expression was upregulated in calcific aortic valve tissue, AVICs treated with osteogenic medium, and a mouse model of CAVD. In vitro, overexpression of PTPN22 induced osteogenic responses, whereas siRNA-mediated PTPN22 knockdown abolished osteogenic\u00a0responses and mitochondrial stress in the presence of osteogenic medium. In vivo, PTPN22 ablation ameliorated aortic valve lesions in a wire injury-induced CAVD mouse model, validating the pathogenic role of PTPN22 in CAVD. Additionally, we discovered a novel compound, 13-hydroxypiericidin A 10-O-\u03b1-D-glucose (1\u2009\u2192\u20096)-\u03b2-D-glucoside (S18), in a marine-derived Streptomyces strain that bound to PTPN22 with high affinity and acted as a novel inhibitor. Incubation with S18 suppressed osteogenic responses and mitochondrial stress in human AVICs induced by osteogenic medium. In mice with aortic valve injury, S18 administration markedly alleviated aortic valve lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PTPN22 plays an essential role in the progression of CAVD, and inhibition of PTPN22 with S18 is a novel option for the further development of potent anti-CAVD drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>Therapeutic inhibition of PTPN22 retards aortic valve calcification through modulating mitochondrial dysfunction in AVICs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-02888-6","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T14:02:12Z","timestamp":1689256932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeted inhibition of PTPN22 is a novel approach to alleviate\u00a0osteogenic responses in aortic valve interstitial cells and aortic valve lesions in mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Shunyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaopeng","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"9","key":"2888_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139\u2013596.","journal-title":"Circulation"},{"issue":"1","key":"2888_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00395-022-00935-6","volume":"117","author":"W Broeders","year":"2022","unstructured":"Broeders W, Bekkering S, El Messaoudi S, Joosten LAB, van Royen N, Riksen NP. Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease? Basic Res Cardiol. 2022;117(1):28.","journal-title":"Basic Res Cardiol"},{"key":"2888_CR3","doi-asserted-by":"crossref","unstructured":"Barahona I, Rada P, Calero-P\u00e9rez S, Grillo-Risco R, Pereira L, Soler-V\u00e1zquez MC, et al. Ptpn1 deletion protects oval cells against lipoapoptosis by favoring lipid droplet formation and dynamics. Cell Death Differ. 2022;29(12):2362\u201380.","DOI":"10.1038\/s41418-022-01023-x"},{"issue":"5","key":"2888_CR4","first-page":"e35","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35\u201371.","journal-title":"Circulation"},{"issue":"28","key":"2888_CR5","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","volume":"39","author":"F Peeters","year":"2018","unstructured":"Peeters F, Meex SJR, Dweck MR, Aikawa E, Crijns H, Schurgers LJ, Kietselaer B. Calcific aortic valve stenosis: hard disease in the heart: A biomolecular approach towards diagnosis and treatment. Eur Heart J. 2018;39(28):2618\u201324.","journal-title":"Eur Heart J"},{"key":"2888_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","volume":"277","author":"KI Cho","year":"2018","unstructured":"Cho KI, Sakuma I, Sohn IS, Jo SH, Koh KK. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. Atherosclerosis. 2018;277:60\u20135.","journal-title":"Atherosclerosis"},{"issue":"3","key":"2888_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/2050640615600115","volume":"4","author":"MR Spalinger","year":"2016","unstructured":"Spalinger MR, Scharl M. The role for protein tyrosine phosphatase non-receptor type 22 in regulating intestinal homeostasis. United European Gastroenterol J. 2016;4(3):325\u201332.","journal-title":"United European Gastroenterol J"},{"key":"2888_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-62703-562-0_13","volume":"1053","author":"L Tautz","year":"2013","unstructured":"Tautz L, Critton DA, Grotegut S. Protein tyrosine phosphatases: structure, function, and implication in human disease. Methods Mol Biol. 2013;1053:179\u2013221.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2888_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41392-022-01038-3","volume":"7","author":"J Pan","year":"2022","unstructured":"Pan J, Zhou L, Zhang C, Xu Q, Sun Y. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. Signal Transduct Target Ther. 2022;7(1):177.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2888_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","volume":"117","author":"A Alonso","year":"2004","unstructured":"Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Protein tyrosine phosphatases in the human genome. Cell. 2004;117(6):699\u2013711.","journal-title":"Cell"},{"issue":"20","key":"2888_CR11","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1042\/CS20171066","volume":"131","author":"D Thompson","year":"2017","unstructured":"Thompson D, Morrice N, Grant L, Le Sommer S, Lees EK, Mody N, Wilson HM, Delibegovic M. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR(-\/-) mouse model of atherosclerosis. Clin Sci (Lond). 2017;131(20):2489\u2013501.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"2888_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cvr\/cvw101","volume":"111","author":"R Gogiraju","year":"2016","unstructured":"Gogiraju R, Schroeter MR, Bochenek ML, Hubert A, M\u00fcnzel T, Hasenfuss G, Sch\u00e4fer K. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice. Cardiovasc Res. 2016;111(3):204\u201316.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2888_CR13","first-page":"1032","volume":"116","author":"CF Yang","year":"2020","unstructured":"Yang CF, Chen YY, Singh JP, Hsu SF, Liu YW, Yang CY, Chang CW, Chen SN, Shih RH, Hsu SD, et al. Targeting protein tyrosine phosphatase PTP-PEST (PTPN12) for therapeutic intervention in acute myocardial infarction. Cardiovasc Res. 2020;116(5):1032\u201346.","journal-title":"Cardiovasc Res"},{"issue":"30","key":"2888_CR14","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1093\/eurheartj\/ehab316","volume":"42","author":"Y Wang","year":"2021","unstructured":"Wang Y, Han D, Zhou T, Chen C, Cao H, Zhang JZ, Ma N, Liu C, Song M, Shi J, et al. DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells. Eur Heart J. 2021;42(30):2935\u201351.","journal-title":"Eur Heart J"},{"issue":"1","key":"2888_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.immuni.2013.06.013","volume":"39","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shaked I, Stanford SM, Zhou W, Curtsinger JM, Mikulski Z, Shaheen ZR, Cheng G, Sawatzke K, Campbell AM, et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity. 2013;39(1):111\u201322.","journal-title":"Immunity"},{"issue":"10","key":"2888_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/aps.2014.80","volume":"35","author":"RJ He","year":"2014","unstructured":"He RJ, Yu ZH, Zhang RY, Zhang ZY. Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin. 2014;35(10):1227\u201346.","journal-title":"Acta Pharmacol Sin"},{"key":"2888_CR17","doi-asserted-by":"crossref","unstructured":"Spalinger MR, Schwarzfischer M, Scharl M. The Role of protein tyrosine phosphatases in inflammasome activation. Int J Mol Sci. 2020;21(15):5481.","DOI":"10.3390\/ijms21155481"},{"key":"2888_CR18","doi-asserted-by":"crossref","unstructured":"Ho WJ, Croessmann S, Lin J, Phyo ZH, Charmsaz S, Danilova L, et al. Systemic inhibition of PTPN22 augments anticancer immunity. J Clin Invest. 2021;131(17):e146950.","DOI":"10.1172\/JCI146950"},{"key":"2888_CR19","doi-asserted-by":"crossref","unstructured":"Wang X, Wei G, Ding Y, Gui X, Tong H, Xu X, et al. Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formation. Blood. 2022;140(9):1038\u201351.","DOI":"10.1182\/blood.2022015554"},{"issue":"1","key":"2888_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000329919","volume":"119","author":"P Saccucci","year":"2011","unstructured":"Saccucci P, Banci M, Cozzoli E, Neri A, Magrini A, Bottini E, Gloria-Bottini F. Atherosclerosis and PTPN22: a study in coronary artery disease. Cardiology. 2011;119(1):54\u20136.","journal-title":"Cardiology"},{"key":"2888_CR21","doi-asserted-by":"crossref","unstructured":"Pertovaara M, Raitala A, Juonala M, K\u00e4h\u00f6nen M, Lehtim\u00e4ki T, Viikari JS, et al. Autoimmunity and atherosclerosis: functional polymorphism of PTPN22 is associated with phenotypes related to the risk of atherosclerosis. The Cardiovascular Risk in Young Finns Study. Clin Exp Immunol. 2007;147(2):265\u20139.","DOI":"10.1111\/j.1365-2249.2006.03278.x"},{"issue":"2","key":"2888_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O\u2019Gara PT, et al. 2017 AHA\/ACC Focused Update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"2888_CR23","doi-asserted-by":"crossref","unstructured":"Li J, Zeng Q, Xiong Z, Xian G, Liu Z, Zhan Q, et al. Trimethylamine N-oxide induces osteogenic responses in human aortic valve interstitial cells in vitro and aggravates aortic valve lesions in mice. Cardiovasc Res. 2022;1(8):2018\u201330.","DOI":"10.1093\/cvr\/cvab243"},{"issue":"7","key":"2888_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/ATVBAHA.117.309021","volume":"37","author":"F Li","year":"2017","unstructured":"Li F, Song R, Ao L, Reece TB, Cleveland JC Jr, Dong N, Fullerton DA, Meng X. ADAMTS5 Deficiency in Calcified Aortic Valves Is Associated With Elevated Pro-Osteogenic Activity in Valvular Interstitial Cells. Arterioscler Thromb Vasc Biol. 2017;37(7):1339\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2888_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2020.07.005","volume":"27","author":"K \u00c9va Sikura","year":"2021","unstructured":"\u00c9va Sikura K, Combi Z, Potor L, Szerafin T, Hendrik Z, M\u00e9hes G, Gergely P, Whiteman M, Beke L, F\u00fcrt\u00f6s I, et al. Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-\u03baB, a link between inflammation and mineralization. J Adv Res. 2021;27:165\u201376.","journal-title":"J Adv Res"},{"key":"2888_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.freeradbiomed.2022.06.246","volume":"188","author":"X Peng","year":"2022","unstructured":"Peng X, Su S, Zeng J, Xie K, Yang X, Xian G, Xiao Z, Zhu P, Zheng S, Xu D, et al. 4-Octyl itaconate suppresses the osteogenic response in aortic valvular interstitial cells via the Nrf2 pathway and alleviates aortic stenosis in mice with direct wire injury. Free Radic Biol Med. 2022;188:404\u201318.","journal-title":"Free Radic Biol Med"},{"key":"2888_CR27","doi-asserted-by":"crossref","unstructured":"Hosen MR, Goody PR, Zietzer A, Xiang X, Niepmann ST, Sedaghat A, et al. Circulating MicroRNA-122\u20135p is associated with a lack of improvement in left ventricular function after transcatheter aortic Valve Replacement and Regulates viability of cardiomyocytes through extracellular vesicles. Circulation. 2022;146(24):1836\u201354.","DOI":"10.1161\/CIRCULATIONAHA.122.060258"},{"issue":"16","key":"2888_CR28","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.7150\/thno.78376","volume":"12","author":"C Liu","year":"2022","unstructured":"Liu C, Wang X, Wang X, Zhang Y, Min W, Yu P, Miao J, Shen W, Chen S, Zhou S, et al. A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cells. Theranostics. 2022;12(16):7158\u201379.","journal-title":"Theranostics"},{"issue":"14","key":"2888_CR29","doi-asserted-by":"publisher","first-page":"9943","DOI":"10.1021\/acs.jmedchem.1c00175","volume":"64","author":"Z Liang","year":"2021","unstructured":"Liang Z, Chen Y, Gu T, She J, Dai F, Jiang H, Zhan Z, Li K, Liu Y, Zhou X, et al. LXR-Mediated Regulation of Marine-Derived Piericidins Aggravates High-Cholesterol Diet-Induced Cholesterol Metabolism Disorder in Mice. J Med Chem. 2021;64(14):9943\u201359.","journal-title":"J Med Chem"},{"issue":"11","key":"2888_CR30","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.7150\/thno.71813","volume":"12","author":"K Phua","year":"2022","unstructured":"Phua K, Chew NW, Kong WK, Tan RS, Ye L, Poh KK. The mechanistic pathways of oxidative stress in aortic stenosis and clinical implications. Theranostics. 2022;12(11):5189\u2013203.","journal-title":"Theranostics"},{"issue":"3","key":"2888_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/ATVBAHA.119.313414","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li Y, Yang P, Liu X, Lu L, Chen Y, Zhong X, Li Z, Liu H, Ou C, et al. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-\u03baB (Nuclear Factor \u03baB) Signals. Arterioscler Thromb Vasc Biol. 2020;40(3):751\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2888_CR32","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1073\/pnas.1619667114","volume":"114","author":"Q Zeng","year":"2017","unstructured":"Zeng Q, Song R, Fullerton DA, Ao L, Zhai Y, Li S, Ballak DB, Cleveland JC Jr, Reece TB, McKinsey TA, et al. Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice. Proc Natl Acad Sci U S A. 2017;114(7):1631\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2888_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.11.017","volume":"364","author":"K Xie","year":"2023","unstructured":"Xie K, Zeng J, Wen L, Peng X, Lin Z, Xian G, Guo Y, Yang X, Li P, Xu D, et al. Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression. Atherosclerosis. 2023;364:1\u20139.","journal-title":"Atherosclerosis"},{"issue":"15","key":"2888_CR34","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1021\/acs.jmedchem.9b00598","volume":"62","author":"X Zhou","year":"2019","unstructured":"Zhou X, Liang Z, Li K, Fang W, Tian Y, Luo X, Chen Y, Zhan Z, Zhang T, Liao S, et al. Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1. J Med Chem. 2019;62(15):7058\u201369.","journal-title":"J Med Chem"},{"issue":"12","key":"2888_CR35","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1021\/jm400248c","volume":"56","author":"Y He","year":"2013","unstructured":"He Y, Liu S, Menon A, Stanford S, Oppong E, Gunawan AM, Wu L, Wu DJ, Barrios AM, Bottini N, et al. A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases. J Med Chem. 2013;56(12):4990\u20135008.","journal-title":"J Med Chem"},{"key":"2888_CR36","doi-asserted-by":"publisher","first-page":"5853238","DOI":"10.1155\/2017\/5853238","volume":"2017","author":"N Garc\u00eda","year":"2017","unstructured":"Garc\u00eda N, Zazueta C, Aguilera-Aguirre L. Oxidative Stress and Inflammation in Cardiovascular Disease. Oxid Med Cell Longev. 2017;2017:5853238.","journal-title":"Oxid Med Cell Longev"},{"key":"2888_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106038","volume":"175","author":"C Wu","year":"2022","unstructured":"Wu C, Zhang Z, Zhang W, Liu X. Mitochondrial dysfunction and mitochondrial therapies in heart failure. Pharmacol Res. 2022;175: 106038.","journal-title":"Pharmacol Res"},{"issue":"5","key":"2888_CR38","first-page":"983","volume":"116","author":"T Toshima","year":"2020","unstructured":"Toshima T, Watanabe T, Narumi T, Otaki Y, Shishido T, Aono T, Goto J, Watanabe K, Sugai T, Takahashi T, et al. Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling. Cardiovasc Res. 2020;116(5):983\u201394.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2888_CR39","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2013.01.048","volume":"144","author":"MR Spalinger","year":"2013","unstructured":"Spalinger MR, Lang S, Weber A, Frei P, Fried M, Rogler G, Scharl M. Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-\u03b3-induced signaling in human monocytes. Gastroenterology. 2013;144(5):978\u2013988.e910.","journal-title":"Gastroenterology"},{"issue":"8","key":"2888_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072384","volume":"8","author":"M Spalinger","year":"2013","unstructured":"Spalinger M, Lang S, Vavricka S, Fried M, Rogler G. Scharl MJPo: Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy. PLoS ONE. 2013;8(8): e72384.","journal-title":"PLoS ONE"},{"issue":"7","key":"2888_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri2998","volume":"11","author":"H H\u00e4cker","year":"2011","unstructured":"H\u00e4cker H, Tseng PH, Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 2011;11(7):457\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2888_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ni.1819","volume":"11","author":"PH Tseng","year":"2010","unstructured":"Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol. 2010;11(1):70\u20135.","journal-title":"Nat Immunol"},{"issue":"5","key":"2888_CR43","doi-asserted-by":"publisher","first-page":"e13004","DOI":"10.1111\/acel.13004","volume":"18","author":"J Miao","year":"2019","unstructured":"Miao J, Liu J, Niu J, Zhang Y, Shen W, Luo C, Liu Y, Li C, Li H, Yang P, et al. Wnt\/\u03b2-catenin\/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell. 2019;18(5):e13004\u201313025.","journal-title":"Aging Cell"},{"issue":"19","key":"2888_CR44","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.106.634139","volume":"114","author":"RM Weiss","year":"2006","unstructured":"Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006;114(19):2065\u20139.","journal-title":"Circulation"},{"issue":"2","key":"2888_CR45","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1161\/ATVBAHA.112.300177","volume":"33","author":"E Branchetti","year":"2013","unstructured":"Branchetti E, Sainger R, Poggio P, Grau JB, Patterson-Fortin J, Bavaria JE, Chorny M, Lai E, Gorman RC, Levy RJ, et al. Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol. 2013;33(2):e66\u201374.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2888_CR46","doi-asserted-by":"crossref","unstructured":"Hofmanis J, Hofmane D, Svirskis S, Mackevics V, Tretjakovs P, Lejnieks A, et al. HDL-C role in acquired aortic valve stenosis patients and its relationship with oxidative stress. Medicina (Kaunas). 2019;55(8):416.","DOI":"10.3390\/medicina55080416"},{"issue":"1","key":"2888_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacbts.2019.10.004","volume":"5","author":"H Liu","year":"2020","unstructured":"Liu H, Wang L, Pan Y, Wang X, Ding Y, Zhou C, Shah AM, Zhao G, Zhang M. Celastrol Alleviates Aortic Valve Calcification Via Inhibition of NADPH Oxidase 2 in Valvular Interstitial Cells. JACC Basic Transl Sci. 2020;5(1):35\u201349.","journal-title":"JACC Basic Transl Sci"},{"key":"2888_CR48","doi-asserted-by":"crossref","unstructured":"Kraler S, Blaser MC, Aikawa E, Camici GG, L\u00fcscher TF. Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. Eur Heart J. 2022;43(7):683\u201397.","DOI":"10.1093\/eurheartj\/ehab757"},{"issue":"3","key":"2888_CR49","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1096\/fj.10-170597","volume":"25","author":"J Strebovsky","year":"2011","unstructured":"Strebovsky J, Walker P, Lang R, Dalpke AH. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus. Faseb J. 2011;25(3):863\u201374.","journal-title":"Faseb J"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02888-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02888-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02888-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T14:03:11Z","timestamp":1689256991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02888-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2888"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02888-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experimental animal study was approved by the Ethics Committee for Animal Experiments of Southern Medical University (ID: NFYY-2021\u20131159). During the course of this study, the protocol was performed in compliance with the Declaration of Helsinki and was approved by Nanfang Hospital, Southern Medical University (ID: NFEC-2021\u2013064).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}